Paul is a member of HMB’s Business and Finance Group and focuses his practice on M&A, private equity transactions, venture capital financing, debt and equity financing and general corporate matters.
Paul works closely with private equity firms, privately held and family-owned businesses, entrepreneurs, emerging companies, financial market participants and investment advisors to address their financial and business matters.
Prior to joining HMB, Paul practiced law at the Indianapolis office of an Am Law 200 firm and the Chicago office of an international law firm where he advised clients on corporate and finance transactions, federal and state securities law, futures and derivatives, regulatory compliance and general business matters. Paul also worked in the Legal and Market Regulation Department at CME Group, Inc., where he investigated and advised on matters pertaining to the rules and regulations of its commodities and derivatives exchanges.
Proactive Counsel, Highly Accessible
Clients appreciate Paul’s proactive counseling, high-quality work product and experience both in-house and with “Big Law.” He is known for his tailored, cost-efficient solutions and his accessibility and responsiveness.
Chicago-Kent College of Law, J.D., cum laude, Student Editor for the Seventh Circuit Review
Iowa State University, B.S., with distinction, in Business Management
HMB represented Quantitative Insights, developer of QuantX, the first-ever FDA-cleared computer-aided breast cancer diagnosis system in radiology, in its sale to Qlarity Imaging, a portfolio company of Paragon Biosciences. Quantitative Insights was founded at the University of Chicago around technology developed at the University and with the support of the University’s Polsky Center for Entrepreneurship and Innovation. Paragon is a…